TrialHaematologica2015

Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.

Joseph Pidala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.